Value of therapeutic drug level monitoring and unbound (free) levels

Seizure

Volumn 17, Issue 6, 2008, Pages 572-575

  Chan, Kenny ^a   Beran, Roy G ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

Epilepsy; Free levels; Therapeutic drug monitoring

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOPIDOGREL; ETIRACETAM; FUROSEMIDE; METOPROLOL; PERINDOPRIL; PHENYTOIN; SIMVASTATIN; SPIRONOLACTONE; VALPROIC ACID;

AGED; ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; EPILEPSY; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; NYSTAGMUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VOMITING;

AGED; ANTICONVULSANTS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS; MALE;

EID: 48349144991     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.12.007     Document Type: Article

References (23)

1. Buchthal F., Svensmark O., and Schiller P.J. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol 2 (1960) 624-630
2. Kutt H., and Penry J.K. Usefulness of blood levels of antiepileptic drugs. Arch Neurol 31 (1974) 283-288
3. Eadie M.J. Plasma level monitoring of anticonvulsants. Clin Pharmacokinet 1 (1976) 52-66
4. Triedman H.M., Fishman R.A., and Yahr M.D. Determination of plasma and cerebrospinal fluid levels of dilantin in the human. Trans Am Neurol Assoc 85 (1960) 166-170
5. Beran R.G., Lewis J.H., Nolte J.L., and Westwood A.P. Use of total and free anticonvulsant serum levels in clinical practice. Clin Exp Neurol 21 (1985) 69-77
6. Eadie M.J. Therapeutic drug monitoring-antiepileptic drugs [see comment]. Brit J Clin Pharmacol 46 (1998) 185-193
7. Schoenenberger R.A., Tanasijevic M.J., Jha A., and Bates D.W. Appropriateness of antiepileptic drug level monitoring. JAMA 274 (1995) 1622-1626
8. Berry D.J., Beran R.G., Plunkeft M.J., Clarke L.A., and Hung W.T. The absorption of gabapentin following high dose escalation. Seizure 12 (2003) 28-36
9. Neels H.M., Sierens A.C., Naelaerts K., Scharpe S.L., Hatfield G.M., and Lambert W.E. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 42 (2004) 1228-1255
10. Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants?. Clin Pharmacokinet 38 (2000) 191-204
11. Richens A. Drug estimation in the treatment of epilepsy. Proc Roy Soc Med 67 (1974) 1227-1229
12. Chadwick D.W. Overuse of monitoring of blood concentrations of antiepileptic drugs. Brit Med J (Clin Res Ed.) 294 (1987) 723-724
13. Chen P., Tanasijevic M.J., Schoenenberger R.A., Fiskio J., Kuperman G.J., and Bates D.W. A computer-based intervention for improving the appropriateness of antiepileptic drug level monitoring. Am J Clin Pathol 119 (2003) 432-438
14. Glauser T.A., and Pippenger C.E. Controversies in blood-level monitoring: reexamining its role in the treatment of epilepsy. Epilepsia 41 Suppl 8 (2000) S6-S15
15. Johannessen S.I., and Tomson T. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?. Clin Pharmacokinet 45 (2006) 1061-1075
16. Theodore W.H. Rational use of antiepileptic drug levels. Pharmacol Therapeut 54 (1992) 297-305
17. Dasgupta A. Clinical utility of free drug monitoring. Clin Chem Lab Med 40 (2002) 986-993
18. Theodore W.H., Yu L., Price B., Yonekawa W., Porter R.J., Kapetanovic I., et al. The clinical value of free phenytoin levels. Ann Neurol 18 (1985) 90-93
19. Perucca E. Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies. Clin Pharmacokinet 9 Suppl 1 (1984) 71-78
20. Beran R.G., Berkovic S.F., Black A.B., Danta G., Hiersemenzel R., Schapel G.J., et al. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Epilepsy Res 63 (2005) 1-9
21. Meinardi H., Van Der Kleijn E., Meijer J.W., and Van Rees H. Absorption and distribution of antiepileptic drugs. Epilepsia 16 (1975) 353-365
22. Patsalos P.N., Froscher W., Pisani F., and van Rijn C.M. The importance of drug interactions in epilepsy therapy. Epilepsia 43 (2002) 365-385
23. Manon-Espaillat R., Burnstine T.H., Remler B., Reed R.C., and Osorio I. Antiepileptic drug intoxication: factors and their significance. Epilepsia 32 (1991) 96-100